Quetiapine fumarate
CAS NO.:111974-72-2
MF:C25H29N3O6S
EINECS NO.:1308068-626-2
MF:C25H29N3O6S
EINECS NO.:1308068-626-2
API016
Quantity
Initially approved by the FDA in 1997,
Quetiapine fumarate is a second-generation atypical antipsychotic used in schizophrenia, major depression,
and bipolar disorder.Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment.
It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as Clozapine and Olanzapine.
Quetiapine fumarate is used in the symptomatic treatment of schizophrenia.
In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder,
as a monotherapy or combined with other drugs.
It may be used to manage depressive episodes in bipolar disorder.
In addition to the above indications, Quetiapine fumarate is used in combination with antidepressant drugs for the treatment of major depression.
